Nyro Research India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -11.97%
- Profit Growth 9.52%
- Ebitda 4.20%
- Net Worth 95.06%
- Total Assets -8.80%
About Nyro Research India
Nyro Research India Private Limited (NRIPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 03 January 2020 (Five years and one month 18 days old ). Its registered office is in Ernakulam, Kerala, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Padmakshiamma Kumari and Thulasingam Bhai serve as directors at the Company.
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73200KL2020PTC061025
- Company No.
061025
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jan 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Nyro Research India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Padmakshiamma Kumari  | Director | 03-Jan-2020 | Current |
| Thulasingam Bhai | Director | 03-Jan-2020 | Current |
Financial Performance of Nyro Research India.
Nyro Research India Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 11.97% decrease. The company also saw a slight improvement in profitability, with a 9.52% increase in profit. The company's net worth Soared by an impressive increase of 95.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nyro Research India?
Unlock access to Nyro Research India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Zastra Innovations Private LimitedThulasingam Bhai is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nyro Research India?
Unlock and access historical data on people associated with Nyro Research India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nyro Research India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nyro Research India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.